Work

IDH1 mutation detection in plasma circulating tumor DNA (ctDNA) and association with clinical response in patients with advanced intrahepatic cholangiocarcinoma (IHC) from the phase III ClarIDHy study.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.4576

Authors: Elia Aguado, Ghassan K. Abou-Alfa, Andrew X. Zhu, Teresa Macarulla, Bin Fan, Parham Nejad, Sung Choe, Liewen Jiang, Camelia Gliser, Shuchi Sumant Pandya, Bin Wu

Institutions: Agios Pharmaceuticals (United States), Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Harvard University, Massachusetts General Hospital, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3031420696

Cites:

Cited by: 26

Related to: 10